Cite
Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway
MLA
Xue Tian, et al. “Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway.” Frontiers in Pharmacology, vol. 13, Mar. 2022. EBSCOhost, https://doi.org/10.3389/fphar.2022.864326.
APA
Xue Tian, Xu Chen, Qianqian Jiang, Qianbin Sun, Tiantian Liu, Yiqin Hong, Yawen Zhang, Yanyan Jiang, Mingyan Shao, Ran Yang, Chun Li, Qiyan Wang, & Yong Wang. (2022). Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.864326
Chicago
Xue Tian, Xu Chen, Qianqian Jiang, Qianbin Sun, Tiantian Liu, Yiqin Hong, Yawen Zhang, et al. 2022. “Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway.” Frontiers in Pharmacology 13 (March). doi:10.3389/fphar.2022.864326.